What Is a ‘Tolerable’ Dose? AACR-Industry Roundtable 2025 Examines Dose Optimization
Experts discussed challenges and opportunities for dose optimization of cancer treatments at the 2025 AACR-Industry Roundtable.
Experts discussed challenges and opportunities for dose optimization of cancer treatments at the 2025 AACR-Industry Roundtable.
FDA approvals issued in third quarter 2023 included a new treatment for prostate cancer harboring BRCA mutations, two new...
Based on estimates from the National Cancer Institute, in 2023, more than 110,000 cases of gynecologic cancers are expected...
Courtney Addison is eternally grateful for the CAR T-cell therapy that sent her son Cayden’s leukemia into remission. But...
In an innovative new initiative to drive progress against cancer, the American Association for Cancer Research (AACR) has announced...
As you say farewell to summer, say hello to the latest installment of Editors’ Picks selected by the editors...
In the span of a decade, the idea that tumor-derived molecules circulating in the bloodstream and other body fluids...
A long and fruitful partnership in the world of cancer research began in 2006 in Hollywood with AACR CEO...
Bacteria account for over 75% of the Earth’s population. And while we often think of these microbes as something...
It sounds like something out of Frankenstein, but a new study in the AACR journal Cancer Discovery suggests that...
Across the surfaces of your mouth, throat, and nasal sinuses, layers of flat cells called squamous cells protect the...